Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Global Neurodegenerative Disease Market - 2022-2029
... 7.4% during the forecast period (2022-2029). Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, among others disorders, affect the neurons in the human brain, leading to the inability of neurons to reproduce themselves. Thus, the ... Read More
-
Parkinson's Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, and Other Drugs); By Distribution Channel; By Route of Ad
... Region; Segment Forecast, 2022 - 2030 The global Parkinson’s disease treatment market size is expected to reach USD 7.74 billion by 2030, according to a new study by Polaris Market Research. The report “Parkinson’s Disease ... Read More
-
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape. Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of ... Read More
-
Global X-Ray Detector Market (2022 Edition)– Analysis By Technology, Portability, Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)
... 5246.84 Million in the year 2021. Major factors driving the market growth include increasing demand for early diagnosis and widening scope of clinical applications of X-ray detectors, growing investments in advancing healthcare facilities & digital ... Read More
-
Neurorehabilitation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
... 3.0 Billion by 2027, exhibiting a growth rate (CAGR) of 12.26% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of ... Read More
-
Neurostimulation Devices Market Size By Product (Transcutaneous Electrical Nerve Stimulation [TENS], Gastric Electric Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Epilepsy, Essential Tremor, Pain Management, Depression, Dystonia, Urinary and Fecal Incontinence, Parkinson's Disease Gastroparesis,), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Urinary and Fecal Incontinence, Parkinson's Disease Gastroparesis,), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The neurostimulation devices market is poised to witness commendable growth ... Read More
-
Global Neuromodulation Devices Market Size study, by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, Others), by Technology (Internal, External) by Application (Parkinson’s Disease, Chronic Pain, Migraine, Epilepsy, Tremor, Depression, Urinary & Faecal Incontinence, Others) by Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial) by End-use (Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others) and Regional Forecasts 2022-2028
... Epilepsy, Tremor, Depression, Urinary & Faecal Incontinence, Others) by Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial) by End-use (Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others) and Regional Forecasts 2022-2028 Global Neuromodulation ... Read More
-
Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027
... an estimated USD 6.0 billion in 2022 and is projected to reach USD 10.4 billion by 2027, at a CAGR of 11.8% during the forecast period. Market growth is driven by factors such as the ... Read More
-
Cannabis Extract Market, by Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol), by Product Type (Oil, Shatter, Wax, Hash, Others (Gummies, Cream, etc.)), by Extract Type (Full Spectrum, Broad Spectrum, Isolates), by Indication (Muscle Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, ... Read More
-
Deep Brain Stimulation Devices Market Size By Application (Parkinsons Disease, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Dystonia, Pain Management, Others), By End-use (Hospitals, Ambulatory Surgical Centers, Others), Industry Analysis Report, Regional Outlook, Growth Potential, COVID-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2030
... Analysis, Competitive Market Share & Forecast, 2022 - 2030 The deep brain stimulation devices market is set to witness substantial growth through 2030 owing to increasing occurrences of neurological illnesses. In addition, surging demand for ... Read More
-
Global Brain Implants Market, By Product Type (Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators), By Application (Chronic Pain, Epilepsy, Parkinson’s Disease, Depression, Essential Tremor, Alzheimer’s Disease), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Region, Competition Forecast & Opportunities, 2027
... Surgery Centers, Others), By Region, Competition Forecast & Opportunities, 2027 Global brain implants market is expected to witness a growth with a robust CAGR in the forecast period. The increasing inclination towards the available better ... Read More
-
Brain Monitoring Market Analysis and Forecast to 2031: By Product Type (Electroencephalography Devices, Magnetencephalography Devices, Transcranial Doppler Devices, Intracranial Pressure Monitor, Cerebral Oximeters, Magnetic Resonance Imaging Devices, Computerized Tomography Devices, Positron Emission Tomography Devices, Sleep Monitoring Devices, Electromyography Devices, Accessories), Procedure (Invasive, Non-invasive), Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington’s Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), and Region
... Monitoring Devices, Electromyography Devices, Accessories), Procedure (Invasive, Non-invasive), Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington’s Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), and Region The global brain monitoring market size was USD ... Read More
-
Deep Brain Stimulation Devices Market, By Application (Parkinson's Disease, Essential Tremor, Dystonia, and Others), by End User (Hospital & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacif
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease ... Read More
-
Brain And Neuroimaging Devices Global Market Report 2022 Including: 1) By Imaging Type: Functional Magnetic Resonance Imaging (fMRI); Computed Tomography (CT); Positron Emission Tomography (PET); Electroencephalography (EEG); Magneto Encephalography (MEG); Other Imaging Types 2) By End-user: Hospitals; Diagnostic Centres; Ambulatory Surgical Centres 3) By Application: Parkinson’s Disease; Traumatic Brain Injury; Epilepsy; Dementia; Sleep Disorders; Other Applications Covering: GE; Siemens; Philips; Canon; Hitachi Medical Systems; Medtronic plc.; EB Neuro S.p.A.; Neurosoft; MinFound Medical Systems Co. ltd.; Elekta
... assess the global brain and neuroimaging devices market. This report focuses on brain and neuroimaging devices market which is experiencing strong growth. The report gives a guide to the brain and neuroimaging devices market which ... Read More
-
Vocal Biomarkers Market, by Therapeutic Application (Psychological Disorders, Respiratory Disorders, and Cardiovascular Disorders), by End User (Hospitals, Health Insurers, Academic & Research Institutions, and Government Organizations), and by Region (No
... Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson’s disease, ... Read More
-
Neurological Biomarkers Market, by Biomarker Type (Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, and Genomics Biomarkers), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Ot
... Centers, Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Neurological biomarkers are biological indicators present ... Read More
-
Neurotech Devices Market Size By Product Type (Neurostimulation {Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS)}, Neuroprostheses, Neurosensing, Neurorehabilitation Devices), By Conditions (Pain Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson's Disease, Depression, Sleep Disorders, Essential Tremor), By End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson's Disease, Depression, Sleep Disorders, Essential Tremor), By End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, ... Read More
-
India Geriatric Care Services Market, by Services (In-Home Care, Hourly Adult Care, Hospice Care, Palliative Care, Assisted Living, and Nursing Home), by Service Provider (Public and Private), and by Disease Indication (Dementia, Parkinson’s Disease, Canc
... Stroke, Osteoarthritis, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Geriatric care management integrates health care and psychological care with other necessary services such as housing, home care services, nutritional services, ... Read More
-
Global Brain Biomarkers Market Size study, By Product Type (Biomarker Test Kits, Biomarker Analyzers), By Disease Indication (Stroke, MND & ALS, Alzheimer’s Disease & Other Dementias, Parkinson’s Disease, Huntington’s Disease), By Application (Diagnosis, Drug Discovery and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028
... and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028 Global Brain Biomarkers Market is valued approximately USD XX million in 2021 and is anticipated to grow ... Read More
-
Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurodegenerative Disorders {Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Others}, Infectious Diseases, Psychotic Disorders, Anxiety Disorders, Trauma, Mood Disord
... Agents, Anticonvulsants, Sedatives and Hypnotics, Antidepressants, Antipsychotics, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, ... Read More
-
Deep Brain Stimulation Devices Market for Parkinson’s Disease, By Product (Single Channel, Dual-Channel), By Region ( North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... 2028 Deep Brain Stimulation (DBS) is a treatment for Parkinson’s disease. It is a minimally invasive medical procedure which involves implanting thin copper electrodes into the cerebral cortex, which deliver electric impulses which either obstruct ... Read More
-
The 2023-2028 World Outlook for Anti-Parkinson's Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Parkinson's Disease Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Neurodegenerative Drugs for Parkinson's Diseases
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Drugs for Alzheimer's and Parkinson's Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
Research Assistance
